October 28, 2016
AstraZeneca pauses two cancer drug trials’ enrolment due to bleeding
AstraZeneca’s high hopes for cancer immunotherapy were dented on Thursday as the recruitment
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
October 28, 2016
Futura to produce extended shelf life condoms
Futura Medical has gotten EU approval to manufacture CSD500, the company’s novel, erectogenic condom
October 28, 2016
Alexion starts phase 3 trials for two ultra-rare diseases
Alexion Pharmaceuticals has announced the initiation of two Phase 3 trials of ALXN1210…
October 28, 2016
Sun Pharma closing down Ocular Technologies buy for $40M plus royalties on its Dry Eye Disease drug (Seciera)
Sun Pharma with its subsidiaries agrees to buy 100% of Ocular Technologies
October 28, 2016
Teva IBM join forces on finding new uses for drugs
IBM and Teva Pharmaceutical Industries Ltd., are expanding their global e-Health alliance to focus on the discovery of new treatment …
October 27, 2016
Bayer profit rises to €1,2 B in Q3 2016
The Bayer Group remained on a path of growth in the third quarter of 2016 and took a major step forward…
October 27, 2016
Newly approved drugs push Lilly’s revenues 5% up, but net income went 3% down
The world’s leading drugmaker Eli Lilly saw a decline in net income for the third…
October 27, 2016
Vertex starts studies for cystic fibrosis treatment
Vertex Pharmaceuticals has announced the planned initiation of two Phase 2 studies to evaluate the next-generation correctors…
October 27, 2016
Allergan to close down buying Motus, relamorelin goes to Phase 3 tests
Allergan on Thursday announced the results of Phase 2b study of the new gastroparesis…
October 27, 2016
Shire spirited up by its antiviral agent (Maribavir) Phase 2 trial results
Shire’s antiviral agent maribavir, studied in the Phase2 trial, has cleared any detectable levels of cytomegalovirus…